Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics, Inc. (LENZ) Long-Term Investments (2022)

LENZ Therapeutics (LENZ) has disclosed Long-Term Investments for 1 consecutive years, with $15.3 million as the latest value for Q4 2022.

  • On a quarterly basis, Long-Term Investments changed N/A to $15.3 million in Q4 2022 year-over-year; TTM through Dec 2022 was $15.3 million, a N/A change, with the full-year FY2022 number at $15.3 million, changed N/A from a year prior.
  • Long-Term Investments was $15.3 million for Q4 2022 at LENZ Therapeutics, up from $13.4 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $15.3 million in Q4 2022 to a low of $6.0 million in Q2 2022.